Skip to main content
Top
Published in: Archives of Dermatological Research 5/2006

01-10-2006 | Original Paper

Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency

Authors: Carolina Pellanda, Evelyne Ottiker, Christoph Strub, Verena Figueiredo, Theo Rufli, Georgios Imanidis, Christian Surber

Published in: Archives of Dermatological Research | Issue 5/2006

Login to get access

Abstract

The application frequency of topical corticosteroids is a recurrently debated topic. Multiple-daily applications are common, although a superior efficacy compared to once-daily application is not unequivocally proven. Only few pharmacokinetic studies investigating application frequency exist. The aim of the study was to investigate the effect of dose (Experiment 1) and application frequency (Experiment 2) on the penetration of triamcinolone acetonide (TACA) into human stratum corneum (SC) in vivo. The experiments were conducted on the forearms of 15 healthy volunteers. In Experiment 1, single TACA doses (300 μg/cm2 and 100 μg/cm2) dissolved in acetone were applied on three sites per arm. In experiment 2, single (1 × 300 μg/cm2) and multiple (3 × 100 μg/cm2) TACA doses were similarly applied. SC samples were harvested by tape stripping after 0.5, 4 and 24 h (Experiment 1) and after 4, 8 and 24 h (Experiment 2). Corneocytes and TACA were quantified by UV/VIS spectroscopy and HPLC, respectively. TACA amounts penetrated into SC were statistically evaluated by a paired-sample t-test. In Experiment 1, TACA amounts within SC after application of 1 × 300 μg/cm2 compared to 1 × 100 μg/cm2 were only significantly different directly after application and similar at 4 and 24 h. In Experiment 2, multiple applications of 3×100 μg/cm2 yielded higher TACA amounts compared to a single application of 1 × 300 μg/cm2 at 4 and 8 h. At 24 h, no difference was observed. In conclusion, using this simple vehicle, considerable TACA amounts were retained within SC independently of dose and application frequency. A low TACA dose applied once should be preferred to a high dose, which may promote higher systemic exposure.
Literature
1.
go back to reference Aalto-Korte K, Turpeinen M (1995) Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 133(2):259–263PubMedCrossRef Aalto-Korte K, Turpeinen M (1995) Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol 133(2):259–263PubMedCrossRef
2.
go back to reference Anissimov YG, Roberts MS (2001) Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 90(4):504–520PubMedCrossRef Anissimov YG, Roberts MS (2001) Diffusion modeling of percutaneous absorption kinetics: 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 90(4):504–520PubMedCrossRef
3.
go back to reference Borsadia S, Ghanem AH, Seta Y, Higuchi WI, Flynn GL, Behl CR, Shah VP (1992) Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations. Skin Pharmacol 5(3):129–145PubMed Borsadia S, Ghanem AH, Seta Y, Higuchi WI, Flynn GL, Behl CR, Shah VP (1992) Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations. Skin Pharmacol 5(3):129–145PubMed
4.
go back to reference Bucks DA, Maibach HI, Guy RH (1985) Percutaneous absorption of steroids: effect of repeated application. J Pharm Sci 74(12):1337–1339PubMedCrossRef Bucks DA, Maibach HI, Guy RH (1985) Percutaneous absorption of steroids: effect of repeated application. J Pharm Sci 74(12):1337–1339PubMedCrossRef
5.
go back to reference Cross SE, Magnusson BM, Winckle G, Anissimov Y, Roberts MS (2003) Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 120(5):759–764PubMedCrossRef Cross SE, Magnusson BM, Winckle G, Anissimov Y, Roberts MS (2003) Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol 120(5):759–764PubMedCrossRef
6.
go back to reference Drake LA, Dinehart SM, Farmer ER (1996) Guidelines of care for the use of topical glucocorticoids. J Am Acad Dermatol 35(4):615–619PubMedCrossRef Drake LA, Dinehart SM, Farmer ER (1996) Guidelines of care for the use of topical glucocorticoids. J Am Acad Dermatol 35(4):615–619PubMedCrossRef
7.
go back to reference Green C, Colquitt JL, Kirby J, Davidson P, Payne E (2004) Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess 8(47):1–134 Green C, Colquitt JL, Kirby J, Davidson P, Payne E (2004) Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess 8(47):1–134
8.
go back to reference ICH (1994) Harmonised tripartite guideline Q2(R1) - Validation of analytical procedures: text and methodology ICH (1994) Harmonised tripartite guideline Q2(R1) - Validation of analytical procedures: text and methodology
9.
go back to reference Jacobi U, Meykadeh N, Sterry W, Lademann J (2003) Effect of the vehicle on the amount of stratum corneum removed by tape stripping. J Deut Dermatol Gesell 1(11):884–889CrossRef Jacobi U, Meykadeh N, Sterry W, Lademann J (2003) Effect of the vehicle on the amount of stratum corneum removed by tape stripping. J Deut Dermatol Gesell 1(11):884–889CrossRef
10.
go back to reference Kalia YN, Alberti I, Naik A, Guy RH (2001) Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacol Physiol 14(Suppl. 1):82–86CrossRef Kalia YN, Alberti I, Naik A, Guy RH (2001) Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacol Physiol 14(Suppl. 1):82–86CrossRef
11.
go back to reference Melendres JL, Bucks DA, Camel E, Wester RC, Maibach HI (1992) In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man. Pharm Res 9(9):1164–1167PubMedCrossRef Melendres JL, Bucks DA, Camel E, Wester RC, Maibach HI (1992) In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man. Pharm Res 9(9):1164–1167PubMedCrossRef
12.
go back to reference Neelissen JA, Arth C, Wolff M, Schrijvers AH, Junginger HE, Bodde HE (2000) Visualization of percutaneous 3H-estradiol and 3H-norethindrone acetate transport across human epidermis as a function of time. Acta Derm Venereol Suppl (Stockh) 208:36–43CrossRef Neelissen JA, Arth C, Wolff M, Schrijvers AH, Junginger HE, Bodde HE (2000) Visualization of percutaneous 3H-estradiol and 3H-norethindrone acetate transport across human epidermis as a function of time. Acta Derm Venereol Suppl (Stockh) 208:36–43CrossRef
13.
go back to reference Reddy MB, Stinchcomb AL, Guy RH, Bunge AL (2002) Determining dermal absorption parameters in vivo from tape strip data. Pharm Res 19(3):292–298PubMedCrossRef Reddy MB, Stinchcomb AL, Guy RH, Bunge AL (2002) Determining dermal absorption parameters in vivo from tape strip data. Pharm Res 19(3):292–298PubMedCrossRef
14.
go back to reference Ritschel WA, Panchagnula R, Stemmer K, Ashraf M (1991) Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol 4(4):235–245PubMedCrossRef Ritschel WA, Panchagnula R, Stemmer K, Ashraf M (1991) Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol 4(4):235–245PubMedCrossRef
15.
go back to reference Roberts MS, Cross SE, Anissimov YG (2004) Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol 17(1):3–16PubMedCrossRef Roberts MS, Cross SE, Anissimov YG (2004) Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol 17(1):3–16PubMedCrossRef
16.
go back to reference Scheuplein RJ, Ross LW (1974) Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 62(4):353–360PubMedCrossRef Scheuplein RJ, Ross LW (1974) Mechanism of percutaneous absorption. V. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 62(4):353–360PubMedCrossRef
17.
go back to reference Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL (1998) Bioequivalence of topical dermatological dosage forms—Methods of evaluation of bioequivalence. Pharm Res 15(2):167–171PubMedCrossRef Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL (1998) Bioequivalence of topical dermatological dosage forms—Methods of evaluation of bioequivalence. Pharm Res 15(2):167–171PubMedCrossRef
18.
go back to reference Stinchcomb AL, Pirot F, Touraille GD, Bunge AL, Guy RH (1999) Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm Res 16(8):1288–1293PubMedCrossRef Stinchcomb AL, Pirot F, Touraille GD, Bunge AL, Guy RH (1999) Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents. Pharm Res 16(8):1288–1293PubMedCrossRef
19.
go back to reference Surber C, Schwarb FP, Smith EW (2005) Tape-stripping technique. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption. Drugs–cosmetics–mechanisms–methodology. Taylor and Francis, Boca Raton, pp 399–410 Surber C, Schwarb FP, Smith EW (2005) Tape-stripping technique. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption. Drugs–cosmetics–mechanisms–methodology. Taylor and Francis, Boca Raton, pp 399–410
20.
go back to reference Taeuber U, Matthes H (1992) Percutaneous absorption of methylprednisolone aceponate after single and multiple dermal application as ointment in male volunteers. Arzneim-Forsch/Drug Res 42(9):1122–1124 Taeuber U, Matthes H (1992) Percutaneous absorption of methylprednisolone aceponate after single and multiple dermal application as ointment in male volunteers. Arzneim-Forsch/Drug Res 42(9):1122–1124
21.
go back to reference Trampisch HJ, Windeler J, Ehle B, Lange S (2000) Trennschärfe statistischer Tests. In: Trampisch HJ, Windeler J (eds) Medizinische Statistik. Springer, Berlin Heildelberg New York, pp 223–233 Trampisch HJ, Windeler J, Ehle B, Lange S (2000) Trennschärfe statistischer Tests. In: Trampisch HJ, Windeler J (eds) Medizinische Statistik. Springer, Berlin Heildelberg New York, pp 223–233
22.
go back to reference Vickers CF (1963) Existence of reservoir in the stratum corneum: experimental proof. Arch Dermatol 88:20–23PubMed Vickers CF (1963) Existence of reservoir in the stratum corneum: experimental proof. Arch Dermatol 88:20–23PubMed
23.
go back to reference Walter K, Kurz H (1988) Binding of drugs to human skin: influencing factors and the role of tissue lipids. J Pharm Pharmacol 40(10):689–693PubMed Walter K, Kurz H (1988) Binding of drugs to human skin: influencing factors and the role of tissue lipids. J Pharm Pharmacol 40(10):689–693PubMed
24.
go back to reference Weigmann H-J, Lindemann U, Antoniou C, Tsikrikas GN, Stratigos AI, Katsambas A, Sterry W, Lademann J (2003) UV/VIS absorbance allows rapid, accurate, and reproducible mass determination of corneocytes removed by tape stripping. Skin Pharmacol Appl Skin Physiol 16(4):217–227PubMedCrossRef Weigmann H-J, Lindemann U, Antoniou C, Tsikrikas GN, Stratigos AI, Katsambas A, Sterry W, Lademann J (2003) UV/VIS absorbance allows rapid, accurate, and reproducible mass determination of corneocytes removed by tape stripping. Skin Pharmacol Appl Skin Physiol 16(4):217–227PubMedCrossRef
25.
go back to reference Weigmann H, Lademann J, v Pelchrzim R, Sterry W, Hagemeister T, Molzahn R, Schaefer M, Lindscheid M, Schaefer H, Shah VP (1999) Bioavailability of clobetasol propionate-quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping. Skin Pharmacol Appl Skin Physiol 12(1–2):46–53PubMedCrossRef Weigmann H, Lademann J, v Pelchrzim R, Sterry W, Hagemeister T, Molzahn R, Schaefer M, Lindscheid M, Schaefer H, Shah VP (1999) Bioavailability of clobetasol propionate-quantification of drug concentrations in the stratum corneum by dermatopharmacokinetics using tape stripping. Skin Pharmacol Appl Skin Physiol 12(1–2):46–53PubMedCrossRef
26.
go back to reference Weigmann HJ, Jacobi U, Antoniou C, Tsikrikas GN, Wendel V, Rapp C, Gers-Barlag H, Sterry W, Lademann J (2005) Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J Biomed Opt 10(1):140091–140097CrossRef Weigmann HJ, Jacobi U, Antoniou C, Tsikrikas GN, Wendel V, Rapp C, Gers-Barlag H, Sterry W, Lademann J (2005) Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J Biomed Opt 10(1):140091–140097CrossRef
27.
go back to reference Wester RC, Noonan PK, Maibach HI (1977) Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 113(5):620–622PubMedCrossRef Wester RC, Noonan PK, Maibach HI (1977) Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 113(5):620–622PubMedCrossRef
28.
go back to reference Wester RC, Maibach H (2005) Effect of single versus multiple dosing in percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs–Cosmetics–Mechanisms–Methodology. Taylor and Francis, Boca Raton, pp 449–457 Wester RC, Maibach H (2005) Effect of single versus multiple dosing in percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs–Cosmetics–Mechanisms–Methodology. Taylor and Francis, Boca Raton, pp 449–457
29.
go back to reference Wester RC, Maibach H (2005) Dermal decontamination and percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs–cosmetics–mechanisms–methodology. Taylor and Francis, Boca Raton, pp 277–289 Wester RC, Maibach H (2005) Dermal decontamination and percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs–cosmetics–mechanisms–methodology. Taylor and Francis, Boca Raton, pp 277–289
30.
go back to reference Wester RC, Maibach H (2005) Interrelationsship in the dose-response of percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs–cosmetics–mechanisms–methodology. Taylor and Francis, Boca Raton, pp 317–329 Wester RC, Maibach H (2005) Interrelationsship in the dose-response of percutaneous absorption. In: Bronaugh RL, Maibach H (eds) Percutaneous absorption: Drugs–cosmetics–mechanisms–methodology. Taylor and Francis, Boca Raton, pp 317–329
Metadata
Title
Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency
Authors
Carolina Pellanda
Evelyne Ottiker
Christoph Strub
Verena Figueiredo
Theo Rufli
Georgios Imanidis
Christian Surber
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Archives of Dermatological Research / Issue 5/2006
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-006-0677-x

Other articles of this Issue 5/2006

Archives of Dermatological Research 5/2006 Go to the issue